About TORIPALIMAB
            
            Class: | Monoclonal Antibody (PD-1 Inhibitor)  
Use: | Treatment of advanced or metastatic melanoma, non-small cell lung cancer (NSCLC), and other solid tumors expressing PD-L1  
Adult dose: | 240 mg administered intravenously every 2 weeks  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Fatigue, rash, pruritus, diarrhea, nausea, immune-related adverse events (e.g., pneumonitis, colitis, hepatitis)  
Contraindications: | History of severe hypersens
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal Antibody (PD-1 Inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of advanced or metastatic melanoma, non-small cell lung cancer (NSCLC), and other solid tumors expressing PD-L1
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: COHERUS BIOSCIE, United States of America
                    
                    
                    Package Size
                    1's - 6ml
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 42735.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        240 mg administered intravenously every 2 weeks
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Fatigue, rash, pruritus, diarrhea, nausea, immune-related adverse events (e.g., pneumonitis, colitis, hepatitis)
                 
             
         
        
        
            
                Contraindications & Precautions
            
            History of severe hypersensitivity to toripalimab or any component of the formulation; active autoimmune disease requiring systemic treatment
         
        
        
            
                Important Warnings
            
            Monitor for immune-mediated adverse reactions; may cause severe or fatal immune-mediated conditions; consider risk of infusion-related reactions; pregnancy and breastfeeding safety not established
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Monoclonal Antibody (PD-1 Inhibitor) medicines available in UAE pharmacies
            
            
            
                Dostarlimab
            
            
            
                Pembrolizumab
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.